Chondropeptix is a biotechnology company developing peptide-based drugs to stimulate cartilage regeneration in joints of patients with cartilage defects, such as osteoarthritis or focal cartilage defects.
Company Details
- Founded
- -
- Address
- Oxfordlaan 70, 4th Floor,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- chondropeptix.com
- HQ
- Maastricht, Limburg
Chondropeptix Questions
Chondropeptix's website is chondropeptix.com
Chondropeptix's LinkedIn profile is https://nl.linkedin.com/company/chondropeptix
Chondropeptix's industry is
Biotechnology Research
Chondropeptix's top competitors are
Complement Pharma,
Cristal Therapeutics,
Graviton Bioscience,
Cimaas Bv,
Bröderna Daniel Fastigheter Ab,
Basic Pharma,
Temple Orthobiologics,
Orthros Medical,
Lila Foundation,
Medace Bv.
Chondropeptix's categories are Biotechnology Research
Chondropeptix's founding year is 2019
